Sex differences in pharmacokinetics and toxicity of antiretroviral therapy

Author： Umeh Obiamiwe C   Currier Judith S  

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.2, Iss.2, 2006-04, pp. : 273-283

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential for modest differences between sexes in antiretroviral therapy pharmacokinetics and adverse events

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 22, Iss. 11, 2006-11 ,pp. : 22-23

Adis International

Access to resources Recommend Favorite

Sex Differences in Antiretroviral Therapy-Associated Intolerance and Adverse Events

By Clark Rebecca  

Drug Safety, Vol. 28, Iss. 12, 2005-01 ,pp. : 1075-1083

Adis International

Access to resources Recommend Favorite

Sex Differences in Pharmacokinetics and Pharmacodynamics

By Soldin Offie P.   Mattison Donald R.  

Clinical Pharmacokinetics, Vol. 48, Iss. 3, 2009-01 ,pp. : 143-157

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of Antiretroviral Therapy in HIV-1-Infected Children

By Fraaij Pieter L.A.   van Kampen Jeroen J.A.   Burger David M.   Ronald de Groot  

Clinical Pharmacokinetics, Vol. 44, Iss. 9, 2005-01 ,pp. : 935-956

Adis International

Access to resources Recommend Favorite

Pharmacogenetics of antiretroviral therapy: genetic variation of response and toxicity

By Martin Annalise M   Nolan David   Gaudieri Silvana   Phillips Elizabeth   Mallal Simon  

Pharmacogenomics, Vol. 5, Iss. 6, 2004-09 ,pp. : 643-655

Future Medicine

Access to resources Recommend Favorite